COIOSDeep risk insights through multi-disciplinary research across the globe
a tall plant in the middle of a field
Item refines Peer-reviewed Added

Depression carried a 65% higher rate of new cardiometabolic disease over 15 years

Among 1858 Dutch adults followed for 15 years, lifetime major depression was associated with higher cardiometabolic disease incidence (HR 1.65), with no one symptom pattern carrying more risk than another.

The Netherlands Study of Depression and Anxiety followed 1858 adults with or without lifetime major depression, none with cardiometabolic disease at baseline. Over 15 years, cardiometabolic disease arose at 21.3 per 1000 person years, and depression carried a hazard ratio of 1.65 against controls. Atypical energy-related symptoms, anhedonia and typical symptoms carried comparable risks, with only the atypical symptoms associated with new diabetes.

Why it is interesting: Tests whether inflammation-linked symptoms carry the risk; the burden looks general to depression rather than symptom-specific.

Source
Journal of Affective Disorders, 2 October 2026
Paper
Depressive symptom profiles and risk of cardiometabolic disease incidence
Authors
Zwiep JC, Milaneschi Y, Vinkers CH, Giltay EJ, Schroevers RA, Penninx BWJH et al.
DOI
10.1016/j.jad.2026.122580
Type
Peer-reviewed article
Design
Prospective cohort (NESDA), n=1858 without baseline cardiometabolic disease, 15-year follow-up, Cox models
Verdict
Refines prior evidence
Driver
Mental health
Free full text
Free to read at the publisher
Abstract — the authors' own words, CC BY

Introduction

Major depressive disorder (MDD) has been linked to increased incidence of cardiometabolic disease (CMD). Depressive symptom profiles associated with inflammation (atypical energy-related symptoms (AES), anhedonia) may carry specific cardiometabolic risk. We investigated whether MDD, AES and anhedonia are associated with higher CMD incidence compared to typical depressive symptoms and control participants. Methods

Data were from the Netherlands Study of Depression and Anxiety (NESDA), including participants with lifetime MDD and non-depressed controls, without baseline CMD (N = 1858). CMD incidence was established over 15-year follow-up using self-report, medication use, and glucose. AES, anhedonia, typical symptoms, and depression severity were derived from the Inventory of Depressive Symptomatology Self-Report. Cox proportional hazard models were adjusted for sociodemographic and lifestyle factors. Results

CMD incidence rate was 21.3/1000 person years. MDD was associated with increased CMD incidence compared to controls (HR = 1.65, 95%CI: 1.30-2.11). In continuous analyses, only AES and depression severity were significantly associated with CMD incidence, though effect sizes were comparable across symptom profiles. When divided into severity tertiles and compared to controls, associations were largely similar across profiles, with no clear dose-response pattern. All profiles were associated with cardiovascular disease incidence, but only AES was associated with diabetes incidence. Discussion

MDD is associated with CMD incidence over 15 years. Depressive symptom profiles did not show differential associations with CMD incidence. Effect sizes across profiles were comparable, suggesting a general rather than symptom-specific depression burden on cardiometabolic health risk. Continued monitoring of cardiometabolic risk factors is warranted for people with a history of depression.

Other drivers in Health today